SFX by Ex Libris Inc.

Title:	Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Source:	Nature [0028-0836] Rolland, M yr:2012

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wyatt, R. "The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens." Science 280.5371 (1998): 1884-8.
description	2.	Haynes, Barton F. "Is developing an HIV-1 vaccine possible?" Current opinion in HIV and AIDS 5.5 (2010): 362-367.
description	3.	Munier, C Mee Ling M. "HIV Vaccines: Progress to Date." Drugs 71.4 (2011): 387-414.
description	4.	Dwek, Raymond A. "Exploiting the defensive sugars of HIV-1 for drug and vaccine design." Nature 446.7139 (2007): 1038-1045.
description	5.	Bates, John T T. "Enhanced responsiveness to antigen contributes more to immunological memory in CD4 T cells than increases in the number of cells." Immunology 116.3 (2005): 318-327.
description	6.	Chan, D C C. "HIV entry and its inhibition." Cell 93.5 (1998): 681-4.
description	7.	Wyatt, R. "The antigenic structure of the HIV gp120 envelope glycoprotein." Nature 393.6686 (1998): 705-11.
description	8.	Zheng, Yong-Hui H. "Newly identified host factors modulate HIV replication." Immunology letters 97.2 (2005): 225-34.
description	9.	Hendrickson, Peter D. "Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody." Nature 393.6686 (1998): 648-59.
description	10.	Johnson, Welkin E., Welkin E. "VIRAL PERSISTENCE: HIV's Strategies of Immune System Evasion." Annual Review of Medicine 53.1 (2002): 499-518.
description	11.	Schwartz, O. "Modulation of the immunological synapse: a key to HIV-1 pathogenesis?" Nature reviews. Immunology 7.4 (2007): 310-7.
description	12.	Wilson, U. "A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield." Science 334.6059 (2011): 1097-1103.
description	13.	Girard, Marc P. "Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review." Vaccine 29.37 (2011): 6191-6218.
description	14.	Willyard, C. "Tiny steps towards an HIV vaccine." Nature 466.7304 (2010).
description	15.	Rerks-Ngarm, S. "Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand." New England Journal of Medicine, The 361.23 (2009): 2209-2220.
description	16.	Leonard G, P. "Molecular engineering and design of therapeutic antibodies." Current opinion in immunology 20.4 (2008): 460-470.
description	17.	Pashov, A. "Targeting carbohydrate antigens in HIV vaccine development." Vaccine 23.17-18 (2005): 2168-2175.
description	18.	Zhang, Z. "Expression of a non-DNA-binding isoform of Helios induces T cell lymphoma in mice." Blood 109.5 (2006): 2190-7.
description	19.	Perrin, H. "New approaches to design HIV-1 T-cell vaccines." Current opinion in HIV and AIDS 5.5 (2010): 368-376.
description	20.	Forsell, Mattias N E N. "Immunogenicity of HIV-1 envelope glycoprotein oligomers." Current opinion in HIV and AIDS 4.5 (2009): 380-387.